Computational and biophysical approaches to protein-protein interaction inhibition of Plasmodium falciparum AMA1/RON2 complex

Journal of Computer-Aided Molecular Design

Volumn 29, Issue 6, 2015, Pages 525-539

  Pihan, Emilie ^a,e   Delgadillo, Roberto F ^a   Tonkin, Michelle L ^c   Pugnière, Martine ^d   Lebrun, Maryse ^b   Boulanger, Martin J ^c   Douguet, Dominique ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITÉ DE MONTPELLIER   (France)

^c UNIVERSITY OF VICTORIA   (Canada)

^d INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

^e UNIVERSITÉ D'ORLÉANS   (France)

Author keywords

Apicomplexa parasites; Fluorescence anisotropy based assay; Invasion; Malaria; Plasmodium falciparum AMA1 RON2 interaction; Virtual screening

Indexed keywords

ANISOTROPY; CRYSTAL STRUCTURE; DIGITAL LIBRARIES; FLUORESCENCE; LIBRARIES; PEPTIDES;

APICOMPLEXUM PARASITE; FLUORESCENCE ANISOTROPY; FLUORESCENCE ANISOTROPY BASED ASSAY; INHIBITORY PEPTIDES; INVASION; MALARIA; PARASITE-; PLASMODIUM FALCIPARUM; PLASMODIUM FALCIPARUM AMA1-RON2 INTERACTION; VIRTUAL SCREENING;

DISEASES;

ANTIMALARIAL AGENT; APICAL MEMBRANE ANTIGEN 1; GOSERELIN; INDINAVIR; MMV 019881; NCG 00015280; PROTOZOAL PROTEIN; RHOPTRY NECK PROTEIN 2; UNCLASSIFIED DRUG; APICAL MEMBRANE ANTIGEN I, PLASMODIUM; CELL SURFACE RECEPTOR; MEMBRANE PROTEIN; MOLECULAR LIBRARY; PARASITE ANTIGEN;

AMINO ACID SEQUENCE; ANISOTROPY; ARTICLE; CELL MEMBRANE; COMPETITIVE INHIBITION; CONSENSUS; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG BINDING SITE; DRUG PROTEIN BINDING; DRUG SCREENING; FLUORESCENCE ANALYSIS; HOST CELL; HOST PARASITE INTERACTION; HYDROPHOBICITY; IC50; LIGAND BINDING; MOLECULAR DOCKING; NONHUMAN; PHARMACOPHORE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RELIABILITY; SURFACE PLASMON RESONANCE; VIRTUAL REALITY; ANTAGONISTS AND INHIBITORS; BIOPHYSICS; CHEMISTRY; COMPUTER AIDED DESIGN; FLUORESCENCE POLARIZATION; METABOLISM; MOLECULAR GENETICS; MOLECULAR LIBRARY; PRECLINICAL STUDY; PROCEDURES; REPRODUCIBILITY; WORKFLOW;

AMINO ACID SEQUENCE; ANTIGENS, PROTOZOAN; ANTIMALARIALS; BIOPHYSICS; COMPUTER-AIDED DESIGN; DRUG EVALUATION, PRECLINICAL; FLUORESCENCE POLARIZATION; INHIBITORY CONCENTRATION 50; MEMBRANE PROTEINS; MOLECULAR DOCKING SIMULATION; MOLECULAR SEQUENCE DATA; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE; REPRODUCIBILITY OF RESULTS; SMALL MOLECULE LIBRARIES; SURFACE PLASMON RESONANCE; WORKFLOW;

EID: 84930872420     PISSN: 0920654X     EISSN: 15734951     Source Type: Journal    
DOI: 10.1007/s10822-015-9842-7     Document Type: Article

References (71)

1. Organization WH (2013) World malaria report 2012
2. Bright AT, Winzeler EA (2013) Epidemiology: resistance mapping in malaria. Nature 498(7455):446-447. doi: 10.1038/498446b
3. Aikawa M, Miller LH, Johnson J, Rabbege J (1978) Erythrocyte entry by malarial parasites. A moving junction between erythrocyte and parasite. J Cell Biol 77(1):72-82
4. Besteiro S, Dubremetz JF, Lebrun M (2011) The moving junction of apicomplexan parasites: a key structure for invasion. Cell Microbiol 13(6):797-805. doi: 10.1111/j.1462-5822.2011.01597.x
5. Riglar DT, Richard D, Wilson DW, Boyle MJ, Dekiwadia C, Turnbull L, Angrisano F, Marapana DS, Rogers KL, Whitchurch CB, Beeson JG, Cowman AF, Ralph SA, Baum J (2011) Super-resolution dissection of coordinated events during malaria parasite invasion of the human erythrocyte. Cell Host Microbe 9(1):9-20. doi: 10.1016/j.chom.2010.12.003
6. Cao J, Kaneko O, Thongkukiatkul A, Tachibana M, Otsuki H, Gao Q, Tsuboi T, Torii M (2009) Rhoptry neck protein RON2 forms a complex with microneme protein AMA1 in Plasmodium falciparum merozoites. Parasitol Int 58(1):29-35. doi: 10.1016/j.parint.2008.09.005
7. Besteiro S, Michelin A, Poncet J, Dubremetz JF, Lebrun M (2009) Export of a Toxoplasma gondii rhoptry neck protein complex at the host cell membrane to form the moving junction during invasion. PLoS Pathog 5(2):e1000309. doi: 10.1371/journal.ppat.1000309
8. Lamarque M, Besteiro S, Papoin J, Roques M, Vulliez-Le Normand B, Morlon-Guyot J, Dubremetz JF, Fauquenoy S, Tomavo S, Faber BW, Kocken CH, Thomas AW, Boulanger MJ, Bentley GA, Lebrun M (2011) The RON2-AMA1 interaction is a critical step in moving junction-dependent invasion by apicomplexan parasites. PLoS Pathog 7(2):e1001276. doi: 10.1371/journal.ppat.1001276
9. Tyler JS, Boothroyd JC (2011) The C-terminus of Toxoplasma RON2 provides the crucial link between AMA1 and the host-associated invasion complex. PLoS Pathog 7(2):e1001282. doi: 10.1371/journal.ppat.1001282
10. Srinivasan P, Beatty WL, Diouf A, Herrera R, Ambroggio X, Moch JK, Tyler JS, Narum DL, Pierce SK, Boothroyd JC, Haynes JD, Miller LH (2011) Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion. Proc Natl Acad Sci USA 108(32):13275-13280. doi: 10.1073/pnas.1110303108
11. Lamarque MH, Roques M, Kong-Hap M, Tonkin ML, Rugarabamu G, Marq JB, Penarete-Vargas DM, Boulanger MJ, Soldati-Favre D, Lebrun M (2014) Plasticity and redundancy among AMA-RON pairs ensure host cell entry of Toxoplasma parasites. Nat Commun 5:4098. doi: 10.1038/ncomms5098
12. Yap A, Azevedo MF, Gilson PR, Weiss GE, O'Neill MT, Wilson DW, Crabb BS, Cowman AF (2014) Conditional expression of apical membrane antigen 1 in Plasmodium falciparum shows it is required for erythrocyte invasion by merozoites. Cell Microbiol 16(5):642-656. doi: 10.1111/cmi.12287
13. Harris KS, Casey JL, Coley AM, Masciantonio R, Sabo JK, Keizer DW, Lee EF, McMahon A, Norton RS, Anders RF, Foley M (2005) Binding hot spot for invasion inhibitory molecules on Plasmodium falciparum apical membrane antigen 1. Infect Immun 73(10):6981-6989. doi: 10.1128/IAI.73.10.6981-6989.2005
14. Richard D, MacRaild CA, Riglar DT, Chan JA, Foley M, Baum J, Ralph SA, Norton RS, Cowman AF (2010) Interaction between Plasmodium falciparum apical membrane antigen 1 and the rhoptry neck protein complex defines a key step in the erythrocyte invasion process of malaria parasites. J Biol Chem 285(19):14815-14822. doi: 10.1074/jbc.M109.080770
15. Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, Tan YY, Dolezal O, Norton RS, Hughes AB, Scanlon D, Foley M (2009) Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning. J Biol Chem 284(14):9361-9371. doi: 10.1074/jbc.M808762200
16. Tonkin ML, Roques M, Lamarque MH, Pugniere M, Douguet D, Crawford J, Lebrun M, Boulanger MJ (2011) Host cell invasion by apicomplexan parasites: insights from the co-structure of AMA1 with a RON2 peptide. Science 333(6041):463-467. doi: 10.1126/science.1204988
17. Vulliez-Le Normand B, Tonkin ML, Lamarque MH, Langer S, Hoos S, Roques M, Saul FA, Faber BW, Bentley GA, Boulanger MJ, Lebrun M (2012) Structural and functional insights into the malaria parasite moving junction complex. PLoS Pathog 8(6):e1002755. doi: 10.1371/journal.ppat.1002755
18. Santos G, Torres NV (2013) New targets for drug discovery against malaria. PLoS One 8(3):e59968. doi: 10.1371/journal.pone.0059968
19. Macraild CA, Anders RF, Foley M, Norton RS (2011) Apical membrane antigen 1 as an anti-malarial drug target. Curr Top Med Chem 11(16):2039-2047
20. Remarque EJ, Faber BW, Kocken CH, Thomas AW (2008) Apical membrane antigen 1: a malaria vaccine candidate in review. Trends Parasitol 24(2):74-84. doi: 10.1016/j.pt.2007.12.002
21. Srinivasan P, Ekanem E, Diouf A, Tonkin ML, Miura K, Boulanger MJ, Long CA, Narum DL, Miller LH (2014) Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria. Proc Natl Acad Sci USA 111(28):10311-10316. doi: 10.1073/pnas.1409928111
22. Srinivasan P, Yasgar A, Luci DK, Beatty WL, Hu X, Andersen J, Narum DL, Moch JK, Sun H, Haynes JD, Maloney DJ, Jadhav A, Simeonov A, Miller LH (2013) Disrupting malaria parasite AMA1-RON2 interaction with a small molecule prevents erythrocyte invasion. Nat Commun 4:2261. doi: 10.1038/ncomms3261
23. Devine SM, Lim SS, Chandrashekaran IR, MacRaild CA, Drew DR, Debono CO, Lam R, Anders RF, Beeson JG, Scanlon MJ, Scammells PJ, Norton RS (2014) A critical evaluation of pyrrolo[2,3-d]pyrimidine-4-amines as Plasmodium falciparum apical membrane antigen 1 (AMA1) inhibitors. Med Chem Commun 5(10):1500-1506
24. Ge X, MacRaild CA, Devine SM, Debono CO, Wang G, Scammells PJ, Scanlon MJ, Anders RF, Foley M, Norton RS (2014) Ligand-induced conformational change of Plasmodium falciparum AMA1 detected using 19F NMR. J Med Chem 57(15):6419-6427. doi: 10.1021/jm500390g
25. Alam A (2014) Bioinformatic identification of peptidomimetic-based inhibitors against Plasmodium falciparum antigen AMA1. Malar Res Treat 2014:642391. doi: 10.1155/2014/642391
26. Mullard A (2012) Protein-protein interaction inhibitors get into the groove. Nat Rev Drug Discov 11(3):173-175. doi: 10.1038/nrd3680
27. Wendt MD (2008) Discovery of ABT-263, a Bcl-family protein inhibitor: observations on targeting a large protein-protein interaction. Expert Opin Drug Discov 3(9):1123-1143. doi: 10.1517/17460441.3.9.1123
28. Wilson AJ (2009) Inhibition of protein-protein interactions using designed molecules. Chem Soc Rev 38(12):3289-3300. doi: 10.1039/b807197g
29. Labbe CM, Laconde G, Kuenemann MA, Villoutreix BO, Sperandio O (2013) iPPI-DB: a manually curated and interactive database of small non-peptide inhibitors of protein-protein interactions. Drug Discov Today 18(19-20):958-968. doi: 10.1016/j.drudis.2013.05.003
30. Ono K, Takeuchi K, Ueda H, Morita Y, Tanimura R, Shimada I, Takahashi H (2014) Structure-based approach to improve a small-molecule inhibitor by the use of a competitive peptide ligand. Angew Chem Int Ed Engl 53(10):2597-2601. doi: 10.1002/anie.201310749
31. Anderson AC (2012) Winning the arms race by improving drug discovery against mutating targets. ACS Chem Biol 7(2):278-288. doi: 10.1021/cb200394t
32. Bourgeas R, Basse MJ, Morelli X, Roche P (2010) Atomic analysis of protein-protein interfaces with known inhibitors: the 2P2I database. PLoS One 5(3):e9598. doi: 10.1371/journal.pone.0009598
33. Pizarro JC, Vulliez-Le Normand B, Chesne-Seck ML, Collins CR, Withers-Martinez C, Hackett F, Blackman MJ, Faber BW, Remarque EJ, Kocken CH, Thomas AW, Bentley GA (2005) Crystal structure of the malaria vaccine candidate apical membrane antigen 1. Science 308(5720):408-411. doi: 10.1126/science.1107449
34. Bai T, Becker M, Gupta A, Strike P, Murphy VJ, Anders RF, Batchelor AH (2005) Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket. Proc Natl Acad Sci USA 102(36):12736-12741. doi: 10.1073/pnas.0501808102
35. Coley AM, Gupta A, Murphy VJ, Bai T, Kim H, Foley M, Anders RF, Batchelor AH (2007) Structure of the malaria antigen AMA1 in complex with a growth-inhibitory antibody. PLoS Pathog 3(9):1308-1319. doi: 10.1371/journal.ppat.0030138
36. Henderson KA, Streltsov VA, Coley AM, Dolezal O, Hudson PJ, Batchelor AH, Gupta A, Bai T, Murphy VJ, Anders RF, Foley M, Nuttall SD (2007) Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition. Structure 15(11):1452-1466. doi: 10.1016/j.str.2007.09.011
37. Crawford J, Tonkin ML, Grujic O, Boulanger MJ (2010) Structural characterization of apical membrane antigen 1 (AMA1) from Toxoplasma gondii. J Biol Chem 285(20):15644-15652. doi: 10.1074/jbc.M109.092619
38. Tonkin ML, Crawford J, Lebrun ML, Boulanger MJ (2013) Babesia divergens and Neospora caninum apical membrane antigen 1 structures reveal selectivity and plasticity in apicomplexan parasite host cell invasion. Protein Sci 22(1):114-127. doi: 10.1002/pro.2193
39. Lim SS, Yang W, Krishnarjuna B, Kannan Sivaraman K, Chandrashekaran IR, Kass I, MacRaild CA, Devine SM, Debono CO, Anders RF, Scanlon MJ, Scammells PJ, Norton RS, McGowan S (2014) Structure and dynamics of apical membrane antigen 1 from Plasmodium falciparum FVO. Biochemistry 53(46):7310-7320. doi: 10.1021/bi5012089
40. Wang G, MacRaild CA, Mohanty B, Mobli M, Cowieson NP, Anders RF, Simpson JS, McGowan S, Norton RS, Scanlon MJ (2014) Molecular insights into the interaction between Plasmodium falciparum apical membrane antigen 1 and an invasion-inhibitory peptide. PLoS One 9(10):e109674. doi: 10.1371/journal.pone.0109674
41. Lee EF, Yao S, Sabo JK, Fairlie WD, Stevenson RA, Harris KS, Anders RF, Foley M, Norton RS (2011) Peptide inhibitors of the malaria surface protein, apical membrane antigen 1: identification of key binding residues. Biopolymers 95(5):354-364. doi: 10.1002/bip.21582
42. Jubb H, Higueruelo AP, Winter A, Blundell TL (2012) Structural biology and drug discovery for protein-protein interactions. Trends Pharmacol Sci 33(5):241-248. doi: 10.1016/j.tips.2012.03.006
43. Azzarito V, Long K, Murphy NS, Wilson AJ (2013) Inhibition of alpha-helix-mediated protein-protein interactions using designed molecules. Nat Chem 5(3):161-173. doi: 10.1038/nchem.1568
44. Owicki JC (2000) Fluorescence polarization and anisotropy in high throughput screening: perspectives and primer. J Biomol Screen 5(5):297-306
45. Chuprina A, Lukin O, Demoiseaux R, Buzko A, Shivanyuk A (2010) Drug- and lead-likeness, target class, and molecular diversity analysis of 7.9 million commercially available organic compounds provided by 29 suppliers. J Chem Inform Model 50(4):470-479. doi: 10.1021/ci900464s
46. Pihan E, Colliandre L, Guichou JF, Douguet D (2012) e-Drug 3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design. Bioinformatics 28(11):1540-1541. doi: 10.1093/bioinformatics/bts186
47. Hawkins PC, Skillman AG, Warren GL, Ellingson BA, Stahl MT (2010) Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database. J Chem Inform Model 50(4):572-584. doi: 10.1021/ci100031x
48. Gasteiger J, Rudolph C, Sadowski J (1990) Automatic generation of 3D-atomic coordinates for organic molecules. Tetrahedron Comput Method 3:537-547
49. Taminau J, Thijs G, De Winter H (2008) Pharao: pharmacophore alignment and optimization. J Mol Graph Model 27(2):161-169. doi: 10.1016/j.jmgm.2008.04.003
50. Koes DR, Camacho CJ (2011) Pharmer: efficient and exact pharmacophore search. J Chem Inform Model 51(6):1307-1314. doi: 10.1021/ci200097m
51. Floris M, Masciocchi J, Fanton M, Moro S (2011) Swimming into peptidomimetic chemical space using pepMMsMIMIC. Nucleic Acids Res 39:W261-269. doi: 10.1093/nar/gkr287 (Web Server issue)
52. Korb O, Stutzle T, Exner TE (2009) Empirical scoring functions for advanced protein-ligand docking with PLANTS. J Chem Inform Model 49(1):84-96. doi: 10.1021/ci800298z
53. Word JM, Lovell SC, Richardson JS, Richardson DC (1999) Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation. J Mol Biol 285(4):1735-1747. doi: 10.1006/jmbi.1998.2401
54. Douguet D (2010) e-LEA3D: a computational-aided drug design web server. Nucleic Acids Res 38:W615-621. doi: 10.1093/nar/gkq322 (Web Server issue)
55. Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 8(2):127-134
56. Reynes C, Host H, Camproux AC, Laconde G, Leroux F, Mazars A, Deprez B, Fahraeus R, Villoutreix BO, Sperandio O (2010) Designing focused chemical libraries enriched in protein-protein interaction inhibitors using machine-learning methods. PLoS Comput Biol 6(3):e1000695. doi: 10.1371/journal.pcbi.1000695
57. Gupta A, Bai T, Murphy V, Strike P, Anders RF, Batchelor AH (2005) Refolding, purification, and crystallization of apical membrane antigen 1 from Plasmodium falciparum. Protein Expr Purif 41(1):186-198. doi: 10.1016/j.pep.2005.01.005
58. Zhang XD (2008) Novel analytic criteria and effective plate designs for quality control in genome-scale RNAi screens. J Biomol Screen 13(5):363-377. doi: 10.1177/1087057108317062
59. Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22(23):3099-3108
60. DeLean A, Munson PJ, Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235(2):E97-E102
61. Sanders MP, Barbosa AJ, Zarzycka B, Nicolaes GA, Klomp JP, de Vlieg J, Del Rio A (2012) Comparative analysis of pharmacophore screening tools. J Chem Inform Model 52(6):1607-1620. doi: 10.1021/ci2005274
62. Vulliez-Le Normand B, Tonkin ML, Lamarque MH, Langer S, Hoos S, Roques M, Saul FA, Faber BW, Bentley GA, Boulanger MJ, Lebrun M (2012) Structural and functional insights into the malaria parasite moving junction complex. PLoS Pathog 8(6):e1002755. doi: 10.1371/journal.ppat.1002755
63. Krier M, Bret G, Rognan D (2006) Assessing the scaffold diversity of screening libraries. J Chem Inform Model 46(2):512-524. doi: 10.1021/ci050352v
64. Monge A, Arrault A, Marot C, Morin-Allory L (2006) Managing, profiling and analyzing a library of 2.6 million compounds gathered from 32 chemical providers. Mol Divers 10(3):389-403. doi: 10.1007/s11030-006-9033-5
65. Spangenberg T, Burrows JN, Kowalczyk P, McDonald S, Wells TN, Willis P (2013) The open access malaria box: a drug discovery catalyst for neglected diseases. PLoS One 8(6):e62906. doi: 10.1371/journal.pone.0062906
66. Sperandio O, Reynes CH, Camproux AC, Villoutreix BO (2010) Rationalizing the chemical space of protein-protein interaction inhibitors. Drug Discov Today 15(5-6):220-229. doi: 10.1016/j.drudis.2009.11.007
67. Li X, He Z, Chen L, Li Y, Li Q, Zhao S, Tao Z, Hu W, Qin L, Chen X (2011) Synergy of the antiretroviral protease inhibitor indinavir and chloroquine against malaria parasites in vitro and in vivo. Parasitol Res 109(6):1519-1524. doi: 10.1007/s00436-011-2427-z
68. Zhang JH, Chung TD, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4(2):67-73
69. Higueruelo AP, Schreyer A, Bickerton GR, Pitt WR, Groom CR, Blundell TL (2009) Atomic interactions and profile of small molecules disrupting protein-protein interfaces: the TIMBAL database. Chem Biol Drug Des 74(5):457-467. doi: 10.1111/j.1747-0285.2009.00889.x
70. Hamon V, Bourgeas R, Ducrot P, Theret I, Xuereb L, Basse MJ, Brunel JM, Combes S, Morelli X, Roche P (2014) 2P2I HUNTER: a tool for filtering orthosteric protein-protein interaction modulators via a dedicated support vector machine. J R Soc Interface 11(90):20130860. doi: 10.1098/rsif.2013.0860
71. Tse C, Shoemaker AR, Adickes J, Anderson MG, Chen J, Jin S, Johnson EF, Marsh KC, Mitten MJ, Nimmer P, Roberts L, Tahir SK, Xiao Y, Yang X, Zhang H, Fesik S, Rosenberg SH, Elmore SW (2008) ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. Cancer Res 68(9):3421-3428. doi: 10.1158/0008-5472.CAN-07-5836